Non-operative management of small bowel obstruction in virgin abdomen: a systematic review

Surgery Today ◽  
2021 ◽  
Author(s):  
Nicole Hew ◽  
Zi Qin Ng ◽  
Ruwan Wijesuriya
2017 ◽  
Vol 45 ◽  
pp. 58-66 ◽  
Author(s):  
Shahab Hajibandeh ◽  
Shahin Hajibandeh ◽  
Nilanjan Panda ◽  
Rao Muhammad Asaf Khan ◽  
Samik Kumar Bandyopadhyay ◽  
...  

2020 ◽  
Author(s):  
Tze W. W. Yang ◽  
Swetha Prabhakaran ◽  
Stephen Bell ◽  
Martin Chin ◽  
Peter Carne ◽  
...  

2019 ◽  
Vol 24 (4) ◽  
pp. 890-898 ◽  
Author(s):  
Benjamin S. C. Fung ◽  
Ramy Behman ◽  
May-Anh Nguyen ◽  
Avery B. Nathens ◽  
Nicole J. Look Hong ◽  
...  

Author(s):  
Edward M. Lawrence ◽  
Perry J. Pickhardt

With optimized technique, the water-soluble contrast (WSC) challenge is effective at triaging patients for operative versus non-operative management of suspected small bowel obstruction (SBO). Standardized study structure and interpretation guidelines aid in clinical efficacy and ease of use. Many tips and tricks exist regarding technique and interpretation, and their understanding may assist the interpreting radiologist. In the future, a CT-based WSC challenge, utilizing oral contrast given as part of the initial CT examination, might allow for a more streamlined algorithm and provide more rapid results.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Alberto Friziero ◽  
Cosimo Sperti ◽  
Gianfranco Da Dalt ◽  
Nicola Baldan ◽  
Gianpietro Zanchettin ◽  
...  

Abstract Background Small bowel obstruction is one of the leading reasons for accessing to the Emergency Department. Food poisoning from Clostridium botulinum has emerged as a very rare potential cause of small bowel obstruction. The relevance of this case report regards the subtle onset of pathognomonic neurological symptoms, which can delay diagnosis and subsequent life-saving treatment. Case presentation A 24-year-old man came to our Emergency Department complaining of abdominal pain, fever and sporadic self-limiting episodes of diplopia, starting 4 days earlier. Clinical presentation and radiological imaging suggested a case of small bowel obstruction. Non-operative management was adopted, which was followed by worsening of neurological signs. On specifically questioning the patient, we discovered that his parents had experienced similar, but milder symptoms. The patient also recalled eating home-made preserves some days earlier. A clinical diagnosis of foodborne botulism was established and antitoxin was promptly administered with rapid clinical resolution. Conclusions Though very rare, botulism can mimic small bowel obstruction, and could be associated with a rapid clinical deterioration if misdiagnosed. An accurate family history, frequent clinical reassessments and involvement of different specialists can guide to identify this unexpected diagnosis.


2013 ◽  
Vol 10 (3) ◽  
pp. 259 ◽  
Author(s):  
AbdulrasheedA Nasir ◽  
LukmanO Abdur-Rahman ◽  
KayodeT Bamigbola ◽  
AdewaleO Oyinloye ◽  
NurudeenT Abdulraheem ◽  
...  

2013 ◽  
Vol 79 (8) ◽  
pp. 794-796 ◽  
Author(s):  
Nicholas Galardi ◽  
Jay Collins ◽  
Kara Friend

Small bowel follow-through (SBFT) is a diagnostic tool commonly used in the management of patients with small bowel obstruction (SBO). This study assessed whether early implementation of Gastrografin SBFT would reduce the time to resolution of the SBO and decrease the time to operative intervention. In this retrospective chart review, 103 patients with the clinical diagnosis of adhesive SBO were evaluated. End points of the study were resolution of SBO with non-operative management or operative intervention. The patient group that had received a SBFT was then compared with those that did not receive a SBFT. There were 103 patients with adhesive SBO who met inclusion criteria for this study. Seventy-two of 103 patients had undergone Gastrografin SBFT and 31 did not. In the SBFT group, mean time to the operating room was 1.0 days after SBFTs, whereas in the group that did not receive SBFT, it was 3.7 days ( P < 0.0001). Mean time to nonoperative resolution of SBO in the SBFT group was 1.8 days and 4.7 days in the no SBFT group ( P < 0.0001). There were no Gastrografin-related complications. Obtaining Gastrografin SBFT in patients with adhesive SBO leads to both a shorter time in identifying the need for operative intervention and to resolution of SBO with nonoperative management. SBFT seems to be a more definitive assessment of whether an SBO will resolve on its own or if operative intervention is necessary.


Sign in / Sign up

Export Citation Format

Share Document